With a passionate focus on Oncology, Accord BioPharma is dedicated to meeting the needs of cancer patients and health care professionals alike. For over 40 years, the founders of Accord BioPharma have dedicated the time and resources of their distinguished scientific leadership team to developing more effective anti-cancer therapies. A pioneering force that has brought biosimilars to the European, Canadian and U.S markets, Accord BioPharma is on a path of delivering better treatments for cancer.
At Accord BioPharma, Innovation is in our Pipeline.
Our current products include:
Accord BioPharma is a division of Accord Healthcare, Inc. All rights reserved. ©
Accord BioPharma does not promote off-label use of its products.
Mutamycin® and Paraplatin® are registered trademarks of Accord Healthcare.